Source: EURLEX
Language: en
Format: md

|  |  |  |
| --- | --- | --- |
| European flag | Official Journal  of the European Union | EN  C series |

---

|  |  |  |
| --- | --- | --- |
|  | C/2024/3613 | 17.6.2024 |

Judgment of the General Court of 24 April 2024 – Verla-Pharm Arzneimittel v EUIPO – Converso (Pherla)

(Case T-357/23)
 [(1)](#ntr1-C_202403613EN.000101-E0001)

(EU trade mark - Opposition proceedings - Application for the EU figurative mark Pherla - Earlier EU word mark VERLA - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)

(C/2024/3613)

Language of the case: English

Parties

Applicant: Verla-Pharm Arzneimittel GmbH & Co. KG (Tutzing, Germany) (represented by: M.-C. Seiler, lawyer)

Defendant: European Union Intellectual Property Office (represented by: T. Frydendahl, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Valeria Converso (San Giorgio a Cremano, Italy) (represented by F. Musella, lawyer)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the Second Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 7 February 2023 (Case R 268/2022-2).

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Annuls the decision of the Second Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 7 February 2023 (Case R 268/2022-2); |

|  |  |
| --- | --- |
| 2. | Dismisses the action as to the remainder; |

|  |  |
| --- | --- |
| 3. | Orders EUIPO to bear its own costs and to pay those incurred by Verla-Pharm Arzneimittel GmbH & Co. KG; |

|  |  |
| --- | --- |
| 4. | Orders Ms Valeria Converso to bear her own costs. |

---

---

ELI: http://data.europa.eu/eli/C/2024/3613/oj

ISSN 1977-091X (electronic edition)

---

[Top](#document1)